UK Markets open in 4 hrs 44 mins

Sarepta Therapeutics, Inc. (SRPT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
109.00-0.26 (-0.24%)
At close: 04:00PM EDT
111.00 +2.00 (+1.83%)
After hours: 06:49PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close109.26
Bid105.50 x 800
Ask111.00 x 1300
Day's range108.61 - 110.96
52-week range61.28 - 113.60
Avg. volume926,570
Market cap9.491B
Beta (5Y monthly)1.21
PE ratio (TTM)N/A
EPS (TTM)-6.11
Earnings date28 Feb 2022 - 04 Mar 2022
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est117.61
  • Zacks

    Sarepta (SRPT) Q2 Earnings Miss, DMD Drugs' Sales Robust

    Strong demand for Sarepta's (SRPT) DMD drugs boosts the top line in the second quarter. However, the wider-than-anticipated losses drive the stock down in after-market trading.

  • Motley Fool

    Sarepta Therapeutics (SRPT) Q2 2022 Earnings Call Transcript

    Good day, ladies and gentlemen, thank you for standing by, and welcome to Sarepta Therapeutics second quarter 2022 earnings conference call. Actual results could materially differ from these forward-looking statements, and any such risks can materially and adversely affect the business, the results of operations, and trading prices for Sarepta's common stock.

  • Zacks

    Sarepta Therapeutics (SRPT) Reports Q2 Loss, Tops Revenue Estimates

    Sarepta Therapeutics (SRPT) delivered earnings and revenue surprises of -147.66% and 6.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?